Anti-cyclic citrullinated peptide antibodies, or anti-CCP antibodies, help in the early diagnosis of rheumatoid arthritis.
Anti-cyclic citrullinated peptide antibodies are anti-keratin antibodies and the normal reference value is negative. It can be used for the diagnosis of rheumatoid joints. Meanwhile the level of anti-cyclic citrullinated peptide antibody is closely related to the severity of joint damage in rheumatoid arthritis.
Anti-cyclic citrullinated peptide antibody is closely related to joint imaging changes, which can predict the progression of rheumatoid arthritis and the presence or absence of kidney damage.
Anti-cyclic citrullinated peptide antibodies and rheumatoid factor are often combined to diagnose rheumatoid arthritis, but anti-cyclic citrullinated peptide antibodies may appear earlier than rheumatoid factor.
If there is swelling and pain in the joints of hands, wrists and feet, accompanied by rheumatoid symptoms such as morning stiffness, fatigue and low-grade fever, and at the same time with positive anti-cyclic citrullinated peptide antibody, it is recommended to consult the Rheumatology and Immunology Department in time to improve the examination under the doctor’s advice, so that the diagnosis can be clarified and treatment can be carried out in time.